This model is an analogue of human Gaucher disease that has been used to test various treatment modalities including ERT, substrate synthesis inhibition therapy, pharmacologic chaperone therapy [8], [10], and gene therapy [11]. The gene discussed is ELF3; the disease is Gaucher disease.